Resultados de la búsqueda 1431-1440 of 12262 for Tetracycline ointment

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with rituximab and to see how well this ...

  2. Oncología (médica) - Ensayos clínicos

    For example, inflammatory bowel disease is a major predisposing factor for colorectal cancer occurrence, implicating inflammation in the development of ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This open-label, exploratory study is designed to evaluate the safety and efficacy of targeted therapies or immunotherapy as single agents or combinations, ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The performance characteristics of the ddPCR assay for the detection of ctDNA mutation in uveal melanoma patients will be assessed by comparing the mutation ...

  5. Oncología (médica) - Ensayos clínicos

    Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, ...

  6. Hematología - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma ...

  7. Oncología (médica) - Ensayos clínicos

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Researchers at Mayo Clinic are developing a Biobank of adult stem cell-rich breast organoids, a new research resource to facilitate normal and cancer stem ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the safety and feasibility of intra-operative Ommaya Reservoir placement during a clinically indicated tumor ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic ...